Close

Celldex (CLDX) RINTEGA Phase 3 ACT V Recommended for Continuation by IDSMB

June 29, 2015 8:10 AM EDT Send to a Friend
Celldex (NASDAQ: CLDX) announced that an independent Data Safety and Monitoring Board (DSMB) recommended continuation of the Phase 3 ACT ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login